[Scintigraphic evaluation of the extent of the neoplastic process in cervical cancer using Co-57-bleomycin in the light of experimental and clinical data].
D015127:9,10-Dimethyl-1,2-benzanthracene; D000328:Adult; D000368:Aged; D000818:Animals; D001761:Bleomycin; D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging*; D003037:Cobalt Radioisotopes; D005260:Female; D006801:Humans; D051379:Mice; D008875:Middle Aged; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging; D002583:Uterine Cervical Neoplasms / Q000000981:diagnostic imaging*
D003037:Cobalt Radioisotopes; D001761:Bleomycin; D015127:9,10-Dimethyl-1,2-benzanthracene
Scyntygraficzna ocena rozległości procesu nowotworowego w raku szyjki macicy za pomoca 57Co-bleomycyny w świetle danych doświadczalnych i klinicznych.